Omkar Pharmachem (BOM:532167) E10: ₹2.69 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532167 Omkar Pharmachem Ltd BOM:532167
52 GF Score
Price ₹16.30
GF Value ₹23.90
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Omkar Pharmachem E10?

Omkar Pharmachem BOM:532167 52 E10 is ₹2.69 as of Mar. 2026. GuruFocus rates BOM:532167 with a GF Score™ of 52/100 and a GF Value™ of ₹23.90 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Omkar Pharmachem's adjusted earnings per share data for the three months ended in Mar. 2026 was ₹26.874. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹2.69 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Omkar Pharmachem was 34.10% per year. The lowest was 27.90% per year. And the median was 31.00% per year.

As of today (2026-07-29), Omkar Pharmachem's current stock price is ₹16.30. Omkar Pharmachem's E10 for the quarter that ended in Mar. 2026 was ₹2.69. Omkar Pharmachem's Shiller PE Ratio of today is 6.06.

During the past 13 years, the highest Shiller PE Ratio of Omkar Pharmachem was 5.78. The lowest was 0.00. And the median was 0.00.


Omkar Pharmachem  (BOM:532167) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Omkar Pharmachem's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=16.30/2.69
=6.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Omkar Pharmachem was 5.78. The lowest was 0.00. And the median was 0.00.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Omkar Pharmachem E10 Related Terms


Omkar Pharmachem E10 Historical Data

* Premium members only.

The historical data trend for Omkar Pharmachem's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Omkar Pharmachem E10 Chart

Omkar Pharmachem Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.07 -0.05 -0.03 -0.02 2.69

Omkar Pharmachem Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.02 -0.02 -0.01 0.00 2.69

BOM:532167 vs CTAS, CPRT, GPN: E10 Comparison

For the Specialty Business Services subindustry, Omkar Pharmachem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Omkar Pharmachem Shiller PE Ratio vs Business Services Industry

For the Business Services industry and Industrials sector, Omkar Pharmachem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Omkar Pharmachem's Shiller PE Ratio falls into.


BOM:532167
52GF Score
Omkar Pharmachem Ltd BOM:532167
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Omkar Pharmachem E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Omkar Pharmachem's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=26.874/164.2724*164.2724
=26.874

Current CPI (Mar. 2026) = 164.2724.

Omkar Pharmachem Quarterly Data

per share eps CPI Adj_EPS
201606 0.375 105.961 0.581
201609 -0.046 105.961 -0.071
201612 -0.049 105.196 -0.077
201703 -0.062 105.196 -0.097
201706 -0.088 107.109 -0.135
201709 -0.050 109.021 -0.075
201712 -0.051 109.404 -0.077
201803 -0.065 109.786 -0.097
201806 -0.091 111.317 -0.134
201809 -0.089 115.142 -0.127
201812 -0.057 115.142 -0.081
201903 -0.184 118.202 -0.256
201906 -0.096 120.880 -0.130
201909 -0.046 123.175 -0.061
201912 -0.050 126.235 -0.065
202003 -0.067 124.705 -0.088
202006 -0.031 127.000 -0.040
202009 -0.010 130.118 -0.013
202012 -0.020 130.889 -0.025
202103 0.282 131.771 0.352
202106 0.054 134.084 0.066
202109 0.048 135.847 0.058
202112 0.081 138.161 0.096
202203 -0.001 138.822 -0.001
202206 0.045 142.347 0.052
202209 0.076 144.661 0.086
202212 0.083 145.763 0.094
202303 -0.005 146.865 -0.006
202306 0.048 150.280 0.052
202309 0.090 151.492 0.098
202312 0.066 152.924 0.071
202403 -0.016 153.035 -0.017
202406 0.049 155.789 0.052
202409 0.088 157.882 0.092
202412 0.084 158.323 0.087
202503 -0.213 157.552 -0.222
202506 0.026 159.755 0.027
202509 0.050 162.289 0.051
202512 0.029 163.281 0.029
202603 26.874 164.272 26.874

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹2.69 mean?
Omkar Pharmachem (BOM:532167) has a E10 of ₹2.69 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Omkar Pharmachem and its competitors.
Is Omkar Pharmachem's E10 too high?
Omkar Pharmachem's current E10 is ₹2.69. Overall, Omkar Pharmachem has a GF Score™ of 52/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Omkar Pharmachem's E10 compare to CTAS and CPRT?
Omkar Pharmachem's E10 of ₹2.69 can be compared against companies in the Business Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Business Services company?
A good E10 depends on the Business Services industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Omkar Pharmachem and its competitors. Omkar Pharmachem's current E10 is ₹2.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Omkar Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Omkar Pharmachem (BOM:532167) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹23.90, compared to a current price of ₹16.30 — trading 31.8% below its estimated fair value. The current E10 is ₹2.69. Omkar Pharmachem's overall GF Score™ is 52/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Omkar Pharmachem (BOM:532167), the current E10 is ₹2.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Omkar Pharmachem (BOM:532167) Overvalued in 2026?

Based on GuruFocus' analysis, Omkar Pharmachem stock appears to be undervalued. The current stock price of ₹16.30 is trading 31.8% below its estimated GF Value™ of ₹23.90. GuruFocus considers Omkar Pharmachem to be Significantly Undervalued.

Key valuation signals for BOM:532167:

  • E10: ₹2.69
  • GF Value™: ₹23.90 vs. price of ₹16.30 (31.8% below fair value)
  • GF Score™: 52/100 with 1 warning sign

No single metric tells the full story. See the BOM:532167 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Omkar Pharmachem Business Description

Address 310, Wall Street-1, 4th Floor, Ellisbridge, Near Gujarat College Cross Road, Ahmedabad, GJ, IND, 380006
Omkar Pharmachem Ltd is an India based company engaged in the provision of business support services.
52GF Score

Get the complete analysis for BOM:532167

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹16.30
Price
₹23.90
GF Value